Header Logo

Connection

PAVAN REDDY to Mice, Inbred C57BL

Back to Details
This is a "connection" page, showing publications PAVAN REDDY has written about Mice, Inbred C57BL.
PAVAN REDDY
Connection Strength
2.016
Mice, Inbred C57BL
  1. Novel regulators of GVHD revealed through microbiome and metabolome patterns across distinct intestinal regions. Blood. 2025 Jun 05; 145(23):2774-2787.
    View in: PubMed
    Score: 0.121
  2. Inflammation-induced epigenetic imprinting regulates intestinal stem cells. Cell Stem Cell. 2024 Oct 03; 31(10):1447-1464.e6.
    View in: PubMed
    Score: 0.115
  3. Mitochondrial complex II in intestinal epithelial cells regulates T cell-mediated immunopathology. Nat Immunol. 2021 11; 22(11):1440-1451.
    View in: PubMed
    Score: 0.094
  4. ATG5-Dependent Autophagy Uncouples T-cell Proliferative and Effector Functions and Separates Graft-versus-Host Disease from Graft-versus-Leukemia. Cancer Res. 2021 02 15; 81(4):1063-1075.
    View in: PubMed
    Score: 0.089
  5. miR-142 controls metabolic reprogramming that regulates dendritic cell activation. J Clin Invest. 2019 04 08; 129(5):2029-2042.
    View in: PubMed
    Score: 0.079
  6. Host NLRP6 exacerbates graft-versus-host disease independent of gut microbial composition. Nat Microbiol. 2019 05; 4(5):800-812.
    View in: PubMed
    Score: 0.079
  7. Mitochondrial Deacetylase SIRT3 Plays an Important Role in Donor T Cell Responses after Experimental Allogeneic Hematopoietic Transplantation. J Immunol. 2018 12 01; 201(11):3443-3455.
    View in: PubMed
    Score: 0.077
  8. Microbial metabolite sensor GPR43 controls severity of experimental GVHD. Nat Commun. 2018 09 10; 9(1):3674.
    View in: PubMed
    Score: 0.076
  9. Murine Models of Steroid Refractory Graft-versus-Host Disease. Sci Rep. 2018 08 20; 8(1):12475.
    View in: PubMed
    Score: 0.076
  10. Genome-Wide STAT3 Binding Analysis after Histone Deacetylase Inhibition Reveals Novel Target Genes in Dendritic Cells. J Innate Immun. 2017; 9(2):126-144.
    View in: PubMed
    Score: 0.067
  11. SAG/Rbx2-Dependent Neddylation Regulates T-Cell Responses. Am J Pathol. 2016 10; 186(10):2679-91.
    View in: PubMed
    Score: 0.066
  12. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat Immunol. 2016 05; 17(5):505-513.
    View in: PubMed
    Score: 0.064
  13. Mature T cell responses are controlled by microRNA-142. J Clin Invest. 2015 Jul 01; 125(7):2825-40.
    View in: PubMed
    Score: 0.061
  14. BET bromodomain inhibition suppresses graft-versus-host disease after allogeneic bone marrow transplantation in mice. Blood. 2015 Apr 23; 125(17):2724-8.
    View in: PubMed
    Score: 0.060
  15. Allogeneic T cell responses are regulated by a specific miRNA-mRNA network. J Clin Invest. 2013 Nov; 123(11):4739-54.
    View in: PubMed
    Score: 0.054
  16. Host-derived CD8+ dendritic cells are required for induction of optimal graft-versus-tumor responses after experimental allogeneic bone marrow transplantation. Blood. 2013 May 16; 121(20):4231-41.
    View in: PubMed
    Score: 0.052
  17. PU.1-dependent transcriptional regulation of miR-142 contributes to its hematopoietic cell-specific expression and modulation of IL-6. J Immunol. 2013 Apr 15; 190(8):4005-13.
    View in: PubMed
    Score: 0.052
  18. Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation. Proc Natl Acad Sci U S A. 2012 Jan 10; 109(2):564-9.
    View in: PubMed
    Score: 0.048
  19. Induction of acute GVHD by sex-mismatched H-Y antigens in the absence of functional radiosensitive host hematopoietic-derived antigen-presenting cells. Blood. 2012 Apr 19; 119(16):3844-53.
    View in: PubMed
    Score: 0.047
  20. Host basophils are dispensable for induction of donor T helper 2 cell differentiation and severity of experimental graft-versus-host disease. Biol Blood Marrow Transplant. 2011 Dec; 17(12):1747-53.
    View in: PubMed
    Score: 0.047
  21. Ikaros-Notch axis in host hematopoietic cells regulates experimental graft-versus-host disease. Blood. 2011 Jul 07; 118(1):192-204.
    View in: PubMed
    Score: 0.045
  22. Interleukin-6 modulates graft-versus-host responses after experimental allogeneic bone marrow transplantation. Clin Cancer Res. 2011 Jan 01; 17(1):77-88.
    View in: PubMed
    Score: 0.044
  23. A crucial role for host APCs in the induction of donor CD4+CD25+ regulatory T cell-mediated suppression of experimental graft-versus-host disease. J Immunol. 2010 Oct 01; 185(7):3866-72.
    View in: PubMed
    Score: 0.044
  24. Immunization with host-type CD8{alpha}+ dendritic cells reduces experimental acute GVHD in an IL-10-dependent manner. Blood. 2010 Jan 21; 115(3):724-35.
    View in: PubMed
    Score: 0.041
  25. Cutting edge: Negative regulation of dendritic cells through acetylation of the nonhistone protein STAT-3. J Immunol. 2009 May 15; 182(10):5899-903.
    View in: PubMed
    Score: 0.040
  26. Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice. J Clin Invest. 2008 Jul; 118(7):2562-73.
    View in: PubMed
    Score: 0.037
  27. Combined Th2 cytokine deficiency in donor T cells aggravates experimental acute graft-vs-host disease. Exp Hematol. 2008 Aug; 36(8):988-96.
    View in: PubMed
    Score: 0.037
  28. Lymphopenia-induced proliferation of donor T cells reduces their capacity for causing acute graft-versus-host disease. Exp Hematol. 2007 Feb; 35(2):274-86.
    View in: PubMed
    Score: 0.034
  29. A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses. Nat Med. 2005 Nov; 11(11):1244-9.
    View in: PubMed
    Score: 0.031
  30. Oral inflammation and microbiome dysbiosis exacerbate chronic graft-versus-host disease. Blood. 2025 Feb 20; 145(8):881-896.
    View in: PubMed
    Score: 0.030
  31. Bacteroides ovatus alleviates dysbiotic microbiota-induced graft-versus-host disease. Cell Host Microbe. 2024 Sep 11; 32(9):1621-1636.e6.
    View in: PubMed
    Score: 0.029
  32. Paradoxical effects of interleukin-18 on the severity of acute graft-versus-host disease mediated by CD4+ and CD8+ T-cell subsets after experimental allogeneic bone marrow transplantation. Blood. 2004 Nov 15; 104(10):3393-9.
    View in: PubMed
    Score: 0.029
  33. Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects. Blood. 2003 Apr 01; 101(7):2877-85.
    View in: PubMed
    Score: 0.025
  34. Interleukin 18 preserves a perforin-dependent graft-versus-leukemia effect after allogeneic bone marrow transplantation. Blood. 2002 Nov 01; 100(9):3429-31.
    View in: PubMed
    Score: 0.025
  35. MicroRNA-142 Is Critical for the Homeostasis and Function of Type 1 Innate Lymphoid Cells. Immunity. 2019 09 17; 51(3):479-490.e6.
    View in: PubMed
    Score: 0.020
  36. Lung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantation. Blood. 2015 Apr 09; 125(15):2435-44.
    View in: PubMed
    Score: 0.015
  37. Blockade of individual Notch ligands and receptors controls graft-versus-host disease. J Clin Invest. 2013 Apr; 123(4):1590-604.
    View in: PubMed
    Score: 0.013
  38. Manipulating the bioenergetics of alloreactive T cells causes their selective apoptosis and arrests graft-versus-host disease. Sci Transl Med. 2011 Jan 26; 3(67):67ra8.
    View in: PubMed
    Score: 0.011
  39. Critical role of host gammadelta T cells in experimental acute graft-versus-host disease. Blood. 2005 Jul 15; 106(2):749-55.
    View in: PubMed
    Score: 0.007
  40. Role of CXCR3-induced donor T-cell migration in acute GVHD. Exp Hematol. 2003 Oct; 31(10):897-902.
    View in: PubMed
    Score: 0.007
  41. Impaired thymic negative selection causes autoimmune graft-versus-host disease. Blood. 2003 Jul 15; 102(2):429-35.
    View in: PubMed
    Score: 0.006
  42. Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays. Blood. 2003 Jul 15; 102(2):763-71.
    View in: PubMed
    Score: 0.006
  43. Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat Med. 2002 Jun; 8(6):575-81.
    View in: PubMed
    Score: 0.006
  44. Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease. J Clin Invest. 2002 May; 109(9):1249-56.
    View in: PubMed
    Score: 0.006
  45. Flt3 ligand therapy for recipients of allogeneic bone marrow transplants expands host CD8 alpha(+) dendritic cells and reduces experimental acute graft-versus-host disease. Blood. 2002 Mar 01; 99(5):1825-32.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.